Impairment of innate immune killing mechanisms by bacteriostatic antibiotics
暂无分享,去创建一个
V. Nizet | Y. Shai | George Y. Liu | S. A. Kristian | N. Sal-Man | R. Gallo | X. Lauth | Yosef Rosenfeld | A. Timmer | Sascha A. Kristian | Neta Sal-Man
[1] H. Juan. Small Colony Variants: a Pathogenic Form of Bacteria that Facilitates Persistent and Recurrent Infections , 2009 .
[2] K. Becker,et al. The small colony variant (SCV) concept -- the role of staphylococcal SCVs in persistent infections. , 2006, Injury.
[3] M. Kagnoff,et al. Cathelicidin Mediates Innate Intestinal Defense against Colonization with Epithelial Adherent Bacterial Pathogens1 , 2005, The Journal of Immunology.
[4] K. Brogden. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.
[5] William A Craig,et al. The importance of bactericidal drugs: future directions in infectious disease. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] R. Benz,et al. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin , 2004, Archives of Microbiology.
[7] Dong-Kuk Lee,et al. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. , 2003, Biochemistry.
[8] V. Nizet,et al. Molecular Genetic Analysis of a Group A Streptococcus Operon Encoding Serum Opacity Factor and a Novel Fibronectin-Binding Protein, SfbX , 2003, Journal of bacteriology.
[9] C. Stratton. Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance , 2003, Emerging infectious diseases.
[10] Tomas Ganz,et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.
[11] Steven W. Taylor,et al. Discovery and Characterization of Two Isoforms of Moronecidin, a Novel Antimicrobial Peptide from Hybrid Striped Bass* , 2002, The Journal of Biological Chemistry.
[12] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[13] M. Barnes,et al. Growth Phase Influences Complement Resistance of Bordetella pertussis , 2002, Infection and Immunity.
[14] Y. Shai,et al. Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.
[15] Takaaki Ohtake,et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.
[16] G. Jürgens,et al. correction: Peptide antibiotics in mast cells of fish , 2001, Nature.
[17] Y. Shai,et al. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. , 1999, The Biochemical journal.
[18] A. Bayer,et al. In Vitro Antibacterial Activities of Platelet Microbicidal Protein and Neutrophil Defensin against Staphylococcus aureus Are Influenced by Antibiotics Differing in Mechanism of Action , 1999, Antimicrobial Agents and Chemotherapy.
[19] H. Kalbacher,et al. Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides* , 1999, The Journal of Biological Chemistry.
[20] H. Sahl,et al. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential , 1996, Infection and immunity.
[21] J. Hoffmann,et al. Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. , 1993, The Journal of biological chemistry.
[22] Cobbs Cg,et al. Bacteriostatic versus bactericidal activity. , 1989 .
[23] C. Cobbs,et al. Bacteriostatic versus bactericidal activity. , 1989, Infectious disease clinics of North America.
[24] A. Dajani,et al. Ampicillin-chloramphenicol interaction against enteric Gram-negative organisms. , 1983, Pediatric infectious disease.